Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: Potential role for nexrutine

Medicine and Dentistry

• Cyclic AMP Responsive Element Binding Protein 100%
• Prostate Cancer 60%
• Promoter Region 60%
• Neoplasm 40%
• Prostate Tumor 40%
• Development 40%
• Phellodendron Amurense Extract 40%
• Analysis 40%
• Cells 40%
• Signal Transduction 20%
• Binding Affinity 20%
• Adenocarcinoma 20%
• Programmed Cell Death 20%
• Tumor Necrosis Factor 20%
• DNA Binding 20%
• Protein Binding 20%
• Prostaglandin E2 20%
• Health Care Cost 20%
• Mutational Analysis 20%
• Prostaglandin Synthase 20%
• Prostate Cancer Cell Line 20%
• Phellodendron Amurense 20%
• Inflammatory Mediator 20%
• Antiproliferative Activity 20%
• Therapeutic Procedure 20%
• Regulatory Mechanism 20%
• Prostate 20%
• Bark 20%

Biochemistry, Genetics and Molecular Biology

• Cyclic AMP Responsive Element Binding Protein 100%
• Promoter Region 60%
• Electric Potential 40%
• Development 40%
• Phellodendron Amurense Extract 40%
• Signal Transduction 20%
• Binding Protein 20%
• Cancer Cell 20%
• Tumor Necrosis Factors 20%
• Apoptosis 20%
• Mediator 20%
• Binding Affinity 20%
• Cyclooxygenase 20%
• Prostaglandin E2 20%
• DNA Binding 20%
• LNCaP 20%
• Mouse 20%
• Transgenics 20%
• Antiproliferative Activity 20%
• Regulatory Mechanism 20%
• Extract 20%
• Cork Tree 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Cyclic AMP Responsive Element Binding Protein 100%
• Prostate Cancer 60%
• Neoplasm 40%
• Phellodendron Amurense Extract 40%
• Prostate Tumor 40%
• Adenocarcinoma 20%
• Tumor Necrosis Factor 20%
• Phellodendron Amurense 20%
• Mouse 20%
• Prostaglandin Synthase 20%
• Prostaglandin E2 20%